(1551637) T cell type abundance and gene expression patterns in the context of clinical progression of treatment-naïve CLL/MBL patients from the OxPLoreD study

Primary Author; Presenting Author(s)

• GG

  Grigore-Aristide Gafencu, BMBS, DPhil

  Bioinformatician
  Oxford Molecular Diagnostic Centre, Department of Oncology, University of Oxford
  Oxford, United Kingdom

  Slides

Co-Author(s)

• 

  Niamh Appleby, MRCPI FRCPath (Haem)

  Senior Clinical Researcher in Haematology
  Oxford Molecular Diagnostic Centre, Department of Oncology, University of Oxford
  Oxford, United Kingdom
• CR

  Charlotte Rich-Griffin, PhD

  Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford
  Oxford, United Kingdom
• KD

  Kyla Dooley, MSc

  Experimental Medicine Division, Nuffield Department of Medicine, University of Oxford
  Oxford, United Kingdom
• HU

  Holm Uhlig, MD, DPhil

  Professor of Paediatric Gastroenterology
  Experimental Medicine Division, Nuffield Department of Medicine, University of Oxford
  Oxford, United Kingdom
• CD

  Calliope Dendrou, BSc, PhD

  Sir Henry Dale Fellow
  Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
  The Kennedy Institute of Rheumatology, University of Oxford
  Oxford, United Kingdom
• DV

  Dimitris Vavoulis, BSc, MRes, MSc, PhD

  Head of Data Science (Oxford Molecular Diagnostic Centre)
  Oxford Molecular Diagnostic Centre, Department of Oncology, University of Oxford, Oxford, United Kingdom Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom, United Kingdom
• 

  Anna Schuh, MD, PhD, FRCP, FRCPath

  Director of Molecular Diagnostics (Oxford Molecular Diagnostic Centre), Professor of Molecular Diagnostics (Department of Oncology)
  Oxford Molecular Diagnostic Centre, Department of Oncology, University of Oxford
  Oxford, United Kingdom